Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...

A patient advocacy group has started a campaign to stop Novo Nordisk from following through ... basal insulins – used to provide a background dose of insulin – are not always suitable for ...

S&P 500 futures steady after record highs. Novo Nordisk and Twilio surge, while Boeing posts $4B loss. Traders eye Fed policy ...

The firm decreased its portfolio allocation in NVO by 19.07% over the last quarter. Novo Nordisk Background Information (This description is provided by the company.) Novo Nordisk A/S is a Danish ...

Basal insulin therapy, currently administered either once or twice daily, is a well-established therapy for diabetes, providing a background ... as daily dosing with Novo Nordisk's Tresiba ...

Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next month. | Telehealth company Hims & Hers is playing offense in a new commercial slated to ...

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

An oral form of Ozempic – Rybelsus, developed by Novo Nordisk, the company that manufactures ... As those developments continue to bubble away in the background, a new market is rapidly expanding.

Robert F. Kennedy Jr. faces high-stakes Senate hearings as he seeks confirmation for Health Secretary. This live blog is now ...

Varadkar has been named as the Hauser Leader of the Harvard Kennedy School Center for Public Leadership for its spring ...